May 14, 2008
AMARIN ANNOUNCES PRIVATE PLACEMENT FOR UP TO $60 MILLION
May 6, 2008
AUSPEX PHARMACEUTICALS ANNOUNCES SERIES B FINANCING; APPOINTMENT OF AJIT GILL AS PRESIDENT & CHIEF EXECUTIVE OFFICER
April 21, 2008
DAVID TIERNEY, M.D. JOINS THOMAS, MCNERNEY & PARTNERS AS ENTREPRENEUR-IN-RESIDENCE
February 20, 2008
OCERA THERAPEUTICS CLOSES $35.5 MILLION SERIES C FINANCING
January 3, 2008
WUXI PHARMATECH TO ACQUIRE APPTEC LABORATORY SERVICES, INC.
November 19, 2007
ORIEL$23 MILLION RICHER: FIRM BRINGS NEW CHAIRMAN
November 16, 2007
PFIZER TO ACQUIRE COLEY PHARMACEUTICAL GROUP
November 1, 2007
TRANZYME PHARMA CLOSES NEW $20 MILLION FINANCING
October 17, 2007
THOMAS, MCNERNEY & PARTNERS EXPANDS TEAM ON EAST AND WEST COASTS
October 16, 2007
ISIS PHARMACEUTICALS AND THOMAS, MCNERNEY & PARTNERS ANNOUNCE THAT THE NEWLY FORMED ALTAIR THERAPEUTICS WILL DEVELOP ANTISENSE DRUGS FOR RESPIRATORY CONDITIONS
January 12, 2007
THOMAS, MCNERNEY & PARTNERS INVESTS IN M2 GROUP HOLDINGS, INC.
December 13, 2006
SOFTSCOPE MEDICAL TECHNOLOGIES, INC. COMPLETES $4 MILLION SERIES A FINANCING
December 11, 2006
GALIL MEDICAL, A LEADER IN CRYOTHERAPY SOLUTIONS, ANNOUNCES $52 MILLION FINANCING
December 6, 2006
THOMAS, MCNERNEY & PARTNERS INVESTS IN NEUROTHERAPEUTICS PHARMA, INC.
November 28, 2006
QUINNOVA PHARMACEUTICALS, INC. COMPLETES $13.6 MILLION SERIES A FINANCING
October 2006
TRANZYME'S TZP-101 NAMED ONE OF MOST PROMISING DRUGS ENTERING PHASE I TRIALS
September 6, 2006
THOMAS, MCNERNEY & PARTNERS CLOSES $375 MILLION LIFE SCIENCE & MEDICAL TECHNOLOGY FUND
August 28, 2006
ZOGENIX, INC. CREATED THROUGH ARADIGM ASSET SALE OF INTRAJECT® NEEDLE-FREE TECHNOLOGY
July 11, 2006
THOMAS, MCNERNEY & PARTNERS IS LEAD INVESTOR IN OSTEOBIOLOGICS, ACQUIRED BY SMITH & NEPHEW
July 10, 2006
OCERA THERAPEUTICS RAISES $12 MILLION SERIES B FINANCING
January 17, 2006
OCERA THERAPEUTICS, A NEW GASTROINTESTINAL AND LIVER-FOCUSED COMPANY, RAISES $14.5M IN SERIES A FINANCING
August 10, 2005
COLEY PHARMACEUTICAL GROUP SETS PRICE FOR INITIAL PUBLIC OFFERING
June 28, 2005
TORAX MEDICAL COMPLETES $10 MILLION SERIES B FINANCING
May 13, 2005
TRANZYME PHARMA COMPLETES US$32 MILLION FINANCING
April 20, 2005
COLEY PHARMACEUTICAL GROUP FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING
March 24, 2005
PFIZER, COLEY PHARMACEUTICAL GROUP ENTER INTO EXCLUSIVE GLOBAL LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF PROMUNE FOR CANCERS
February 21, 2005
AXIOMED SPINE CORPORATION SECURES $18 MILLION IN SERIES B FINANCING
December 13, 2004
THOMAS MCNERNEY & PARTNERS INVESTS IN LEPTOS
BIOMEDICAL, INC.
November 8, 2004
THOMAS, MCNERNEY & PARTNERS ANNOUNCES PRATIK SHAH, PH.D. AS NEW VENTURE PARTNER IN SAN FRANCISCO OFFICE
September 29, 2004
COLEY PHARMACEUTICAL GROUP RAISES $25 MILLION IN PRIVATE FINANCING
July 7, 2004
THOMAS, McNERNEY & PARTNERS INVESTS IN SOLSTICE NEUROSCIENCES, INC.
February 13, 2004
THOMAS, McNERNEY & PARTNERS INVESTS IN CLARUS THERAPEUTICS, INC.
December 23, 2003
THOMAS, McNERNEY & PARTNERS INVESTS IN ROSEDALE
MEDICAL, INC.
October 3, 2003
OSTEOBIOLOGICS, INC. CLOSES $9.2 MILLION FINANCING
August 25, 2003
COLEY PHARMACEUTICAL GROUP ANNOUNCES $35 MILLION PRIVATE FINANCING
May 6, 2003
THOMAS, MCNERNEY & PARTNERS, LLC, RAISES $216 MILLION FOR ITS INAUGURAL HEALTH CARE PRIVATE EQUITY FUND
